Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Equity Income (2022 - 2023)

Historic Equity Income for Silo Pharma (SILO) over the last 2 years, with Q2 2023 value amounting to -$3508.0.

  • Silo Pharma's Equity Income rose 9410.53% to -$3508.0 in Q2 2023 from the same period last year, while for Dec 2023 it was -$78329.0, marking a year-over-year change of. This contributed to the annual value of -$3118.0 for FY2023, which is 9905.86% up from last year.
  • As of Q2 2023, Silo Pharma's Equity Income stood at -$3508.0, which was up 9410.53% from -$74821.0 recorded in Q4 2022.
  • In the past 5 years, Silo Pharma's Equity Income registered a high of -$3508.0 during Q2 2023, and its lowest value of -$74821.0 during Q4 2022.